|Articles|March 7, 2022
UK Regulator Cites CluePoints’ Solutions In Updated Guidance
MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring.
Advertisement
CluePoints has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s weight behind CluePoints’ statistical monitoring solutions.
The document, Oversight and Monitoring Activities, covers a broad range of clinical trial activities, including the use of committees to manage trials or review emerging safety data, the central review of clinical trial data, data management processes, and pharmacovigilance signal detection.
Read more about the updated guidance here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
